SCHEMBL1127571

SCHEMBL1127571

OCCOc1ccc([S+](c2ccc(OCCO)cc2)c2ccc(Sc3ccc([S+](c4ccc(OCCO)cc4)c4ccc(OCCO)cc4)cc3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
RECQL P46063 1/20 0.47
NR1I2 O75469 1/20 0.43
GAA P10253 3/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
CYP3A4 P08684 1/20 0.40
LMNA P02545 2/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
APP P05067 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
ALOX5AP P20292 1/20 0.34
CYP19A1 P11511 1/20 0.33
THRB P10828 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10248296 0.94 ALDH1A1 (0.55) ALDH1A1RECQLNR1I2GAASMN1; SMN2
SCHEMBL31534662 0.94 ALDH1A1 (0.42) ALDH1A1RECQLNR1I2GAASMN1; SMN2
SCHEMBL30513317 0.94 ALDH1A1 (0.42) ALDH1A1RECQLNR1I2GAASMN1; SMN2
SCHEMBL2630455 0.89 NR1I2 (0.40) ALDH1A1RECQLNR1I2GAASMN1; SMN2
SCHEMBL1789304 0.89 GAA (0.59) ALDH1A1RECQLNR1I2GAALMNA
SCHEMBL890770 0.89 ALDH1A1 (0.58) ALDH1A1RECQLNR1I2GAASMN1; SMN2
SCHEMBL10225002 0.88 L3MBTL1 (0.55) ALDH1A1NR1I2GAALMNAHPGD
SCHEMBL17272815 0.86 ALDH1A1 (0.36) ALDH1A1RECQLNR1I2GAASMN1; SMN2
SCHEMBL1792905 0.85 GAA (0.65) ALDH1A1RECQLGAASMN1; SMN2LMNA
SCHEMBL1788549 0.85 GAA (0.69) ALDH1A1RECQLGAASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709598-B2 Fluorinated alkyl fluorophoshoric acid salts of onium and transition metal complex SAN-APRO LIMITED (JP) 2010-05-04 US claimed
US-20070225458-A1 Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex SAN-APRO LIMITED (JP) 2007-09-27 US claimed
EP-1752463-A1 NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX San-Apro Limited (JP) 2007-02-14 EP claimed
US-20260116071-A1 METHOD OF MANUFACTURING LIQUID EJECTION HEAD, AND LIQUID EJECTION HEAD CANON KK (JP) 2026-04-30 US disclosed
EP-4696511-A1 INK-JET RECORDING HEAD Canon Kabushiki Kaisha (JP) 2026-02-18 EP disclosed
US-20260042918-A1 PHOTOSENSITIVE RESIN COMPOSITION, LIQUID-REPELLENT ANTI-FOULING FILM, AND INKJET RECORDING HEAD CANON KK (JP) 2026-02-12 US disclosed
US-20260042294-A1 INK-JET RECORDING HEAD CANON KK (JP) 2026-02-12 US disclosed
EP-4692937-A1 NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR PRODUCING SAME, HOLLOW STRUCTURE, ELECTRONIC COMPONENT, AND ELASTIC WAVE FILTER Toray Industries, Inc. (JP) 2026-02-11 EP disclosed
EP-4667537-A1 PRIMER COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING LAMINATE TOKYO OHKA KOGYO CO., LTD. (JP) 2025-12-24 EP disclosed
US-20250271751-A1 PHOTOSENSITIVE COMPOSITION, PHOTOSENSITIVE FILM, LOWER LAYER FILM, METHOD FOR PRODUCING STRUCTURE HAVING PHASE-SEPARATED STRUCTURE, AND COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2025-08-28 US disclosed
US-20250189895-A1 METHOD OF MANUFACTURING PLATED ARTICLE TOKYO OHKA KOGYO CO., LTD. (JP) 2025-06-12 US disclosed
US-20080311511-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE RESIN LAMINATE, AND METHOD FOR PATTERN FORMING TOKYO OHKA KOGYO CO., LTD. (JP) 2008-12-18 US disclosed
US-7435526-B2 Positive photosensitive composition FUJIFILM CORPORATION (JP) 2008-10-14 US disclosed
US-7399502-B2 Discharge orifice is coated with a cured film having epoxy, perfluroralkyl, and alkylsiloxane groups; cationic polymerization catalyst; water repellent agent; film having excellent water-repellency on a substrate surface CANON KABUSHIKI KAISHA (JP) 2008-07-15 US disclosed
US-7329715-B2 Abrasion resistant coatings by siloxane oligomers YAZAKI CORPORATION (JP) 2008-02-12 US disclosed
US-7285579-B2 Solventless, non-polluting radiation curable coatings POLYSET COMPANY, INC. (US) 2007-10-23 US disclosed
US-20070225458-A1 Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex SAN-APRO LIMITED (JP) 2007-09-27 US disclosed
US-20070217823-A1 CHARGING MEMBER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS CANON KABUSHIKI KAISHA (JP) 2007-09-20 US disclosed
US-20070003871-A1 Positive photosensitive composition FUJI PHOTO FILM CO., LTD. 2007-01-04 US disclosed
US-20060235178-A1 Abrasion resistant coatings by siloxane oligomers STOWE WOODWARD LLC 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260116071-A1 METHOD OF MANUFACTURING LIQUID EJECTION HEAD, AND LIQUID EJECTION HEAD ASIC1, PTGER1, PELP1 ALDH1A1 586/4885RECQL 2952/4885NR1I2 2392/4885
US-20260042294-A1 INK-JET RECORDING HEAD SEM1, ASIC1, C9 ALDH1A1 4015/4885RECQL 1198/4885NR1I2 4453/4885
US-20070225458-A1 Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex AS3MT, TTR, PFAS ALDH1A1 3745/4885RECQL 4206/4885NR1I2 3908/4885
US-20260042918-A1 PHOTOSENSITIVE RESIN COMPOSITION, LIQUID-REPELLENT ANTI-FOULING FILM, AND INKJET RECORDING HEAD MLLT1, MLLT3, ERCC1 ALDH1A1 1866/4885RECQL 1932/4885NR1I2 1436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.